Pew Testifies Before D.C. Council Committee on Health Implications of ‘Baby Bonds’

Research on links between wealth and health status informs lawmakers ahead of bill vote

Pew Testifies Before D.C. Council Committee on 'Baby Bonds'

On May 25, Stefanie Carignan, a senior associate with The Pew Charitable Trusts’ Health Impact Project, testified in Washington at a public hearing of the D.C. Council’s Business and Economic Development Committee about the project’s findings on the potential health effects of Bill 24-0236, the Child Wealth Building Act of 2021. The bill would automatically provide a D.C. government-sponsored trust fund, or “baby bond,” for babies born into low- and moderate-income households. Her remarks emphasized the connections between wealth and health status and the bill’s potential impacts on the city’s racial wealth gap.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.